BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8129921)

  • 21. [Concomitant radiotherapy and chemotherapy in the treatment of cancers of the upper respiratory and digestive tracts].
    Calais G; Le Floch O
    Bull Cancer Radiother; 1996; 83(4):321-9. PubMed ID: 9081334
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of polaprezinc on oral mucositis, irradiation period, and time to discharge in patients with head and neck cancer.
    Suzuki A; Kobayashi R; Shakui T; Kubota Y; Fukita M; Kuze B; Aoki M; Sugiyama T; Mizuta K; Itoh Y
    Head Neck; 2016 Sep; 38(9):1387-92. PubMed ID: 27002591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
    Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
    BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous cell carcinoma of the head and neck: management after excisional biopsy of a solitary metastatic neck node.
    Mack Y; Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
    Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):619-22. PubMed ID: 8454479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
    Sher DJ; Balboni TA; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Tishler RB
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1405-11. PubMed ID: 21177045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of parotid lymph node metastases by irradiation.
    Wang CC
    Cancer; 1982 Jul; 50(2):223-5. PubMed ID: 7083129
    [No Abstract]   [Full Text] [Related]  

  • 28. Late oral complications following radiotherapy for head and neck cancers.
    Chua DT; Tian Y; Wei WI
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1215-24. PubMed ID: 17892422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation.
    Reddy SP; Marks JE
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):797-802. PubMed ID: 9128954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Delineation of the lymph nodes for head neck cancers].
    Lapeyre M; Miroir J; Biau J
    Cancer Radiother; 2014 Oct; 18(5-6):572-6. PubMed ID: 25179252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
    Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
    Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of chemotherapy and radiotherapy in sterilizing cervical nodal disease in squamous cell carcinoma of the head and neck.
    Moore MG; Bhattacharyya N
    Laryngoscope; 2005 Apr; 115(4):570-3. PubMed ID: 15805860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of small lymph node metastases with evidence of extracapsular extension: clinical implications in patients with head and neck squamous cell carcinoma.
    Ghadjar P; Simcock M; Schreiber-Facklam H; Zimmer Y; Gräter R; Evers C; Arnold A; Wilkens L; Aebersold DM
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1366-72. PubMed ID: 20231070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microsatellite molecular analysis of the resection margins and laterocervical lymph nodes in the planning of complementary postoperative radiotherapy in early squamous carcinoma (stage I and II) of the head and neck].
    Gallo O
    Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):383-5. PubMed ID: 11398673
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer.
    Donath D; Vuong T; Shenouda G; MacDonald B; Tabah R
    Eur Arch Otorhinolaryngol; 1995; 252(6):321-4. PubMed ID: 8679148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elective irradiation of the neck in patients with primary carcinoma of the head and neck.
    Bagshaw MA; Thompson RW
    JAMA; 1971 Jul; 217(4):456-8. PubMed ID: 5109034
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
    Parsons JT; Mendenhall WM
    J Natl Cancer Inst; 1996 Oct; 88(19):1407-8. PubMed ID: 8827019
    [No Abstract]   [Full Text] [Related]  

  • 38. Elective irradiation of subclinical disease in cancers of the head and neck.
    Fletcher GH
    Cancer; 1972 Jun; 29(6):1450-4. PubMed ID: 5031239
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Cancers of the head and neck region in developing countries. Radiother Oncol. 2003 Apr;67(1):1-2.
    Gupta T; Laskar SG
    Radiother Oncol; 2004 Feb; 70(2):207-8; author reply 208-9. PubMed ID: 15028409
    [No Abstract]   [Full Text] [Related]  

  • 40. Persistent dysphagia after head and neck radiotherapy: a common and under-reported complication with significant effect on non-cancer-related mortality.
    Szczesniak MM; Maclean J; Zhang T; Graham PH; Cook IJ
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):697-703. PubMed ID: 25239671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.